For instance, a 2017 study in 169 people with eczema found that around 40% tried a gluten-free diet to reduce their symptoms. Of them, 51.4% reported improvements after cutting out gluten.

Easy recurrence and strong treatment side effects significantly limit the clinical treatment of allergic dermatitis. The human trace element selenium (Se) plays essential roles in redox regulation ...

Background Incontinence-associated dermatitis (IAD) is an inflammation of the skin due to contact with urine or stool. IAD occurs in people with involuntary loss of urine or stool (incontinence). The ...

The Phase 1b trial is designed to evaluate the safety, tolerability, pharmacokinetics, target engagement, and early signs of efficacy of ENV-294 in patients with moderate to severe atopic dermatitis.

The FDA has extended its review of Incyte’s supplemental New Drug Application (sNDA) for ruxolitinib cream 0.75% (Opzelura) for the treatment of mild to moderate atopic dermatitis (AD) in children ...

By Breakingviews The brain-trust behind the benchmark S&P 500 Index (SPX) made a bold move: it did nothing. For the first time in more than three years, no new companies were added to the tracker ...

Feardemic will release The Brotherhood-developed survival horror game Stasis for PlayStation 5, Xbox Series, PlayStation 4, Xbox One, and Switch on June 26 for $9.99, the publisher announced.

The hidden triggers behind eczema flare-ups Understanding what sparks eczema episodes has become crucial for effective management. While researchers haven’t pinpointed a single cause, evidence ...

Primary Source JAMA Dermatology Source Reference: Lin T-L, et al "Psoriasis risk in patients with atopic dermatitis treated with dupilumab" JAMA Dermatol 2025; DOI: 10.1001/jamadermatol.2025.1578.

Video: What to Know About Treatment of Atopic Dermatitis Based on the 2024 AAD Guidelines —Megan Rogge, MD, associate professor of dermatology at UT Health in Houston, shares her opinion on the ...

Topical ruxolitinib cream significantly improved the signs and symptoms of atopic dermatitis (AD) while maintaining a favorable safety profile in children aged 2 to 11 years, according to the results ...